LexDanaLexDanabeta
Inventor

Ozan ALKAN

Inventor
US

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
C12NMicroorganisms or enzymes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07DHeterocyclic compounds13%
C07KPeptides13%
PatentTitleYear
12,577,573Synthetic production of single-stranded adeno associated viral DNA vectors202612,442,015Closed-ended DNA vectors obtainable from cell-free synthesis and process for obtaining ceDNA vectors202511,787,781Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023Patents assigned to CELATOR PHARMACEUTICALS INC (1)· patent assignee history
2023–2026Based in US· patent location history
2025–2026Patents assigned to GENERATION BIO CO (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENERATION BIO CO22025–2026
CELATOR PHARMACEUTICALS INC12023
Locations
LocationPatentsSpan
US32023–2026